Stockscreener 앱 받기
27.12
0.18%
0.0522
전일 마감가:
$27.07
열려 있는:
$27.64
하루 거래량:
328.27K
Relative Volume:
1.09
시가총액:
$15.92B
수익:
$21.23B
순이익/손실:
$924.30M
주가수익비율:
22.10
EPS:
1.2272
순현금흐름:
$2.22B
1주 성능:
+1.92%
1개월 성능:
+7.19%
6개월 성능:
+15.80%
1년 성능:
+35.06%
1일 변동 폭
$27.12
$27.64
1주일 범위
$26.52
$27.64
52주 변동 폭
$18.94
$30.46
프레제니우스메디칼케어 Stock (FMS) Company Profile
FMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FMS
Fresenius Medical Care Ag Adr
|
27.13 | 15.89B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
HCA
Hca Healthcare Inc
|
422.39 | 99.74B | 72.70B | 6.88B | 7.29B | 23.81 |
|
THC
Tenet Healthcare Corp
|
197.03 | 17.71B | 20.69B | 2.40B | 1.55B | 15.62 |
|
EHC
Encompass Health Corp
|
123.83 | 12.53B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
202.92 | 13.06B | 16.08B | 1.20B | 1.06B | 17.82 |
프레제니우스메디칼케어 Stock (FMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-02 | 다운그레이드 | UBS | Neutral → Sell |
| 2024-12-02 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2024-11-06 | 개시 | Berenberg | Buy |
| 2024-01-08 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-11-24 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2023-11-17 | 업그레이드 | Societe Generale | Hold → Buy |
| 2023-08-14 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-08-01 | 재개 | Citigroup | Neutral |
| 2023-07-12 | 개시 | Goldman | Buy |
| 2023-03-07 | 개시 | Bernstein | Mkt Perform |
| 2023-01-03 | 다운그레이드 | Jefferies | Buy → Underperform |
| 2022-10-26 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2022-10-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-10-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-06-27 | 업그레이드 | Jefferies | Underperform → Buy |
| 2022-02-11 | 다운그레이드 | Jefferies | Hold → Underperform |
| 2021-11-23 | 개시 | HSBC Securities | Hold |
| 2021-11-11 | 업그레이드 | Jefferies | Underperform → Hold |
| 2021-02-04 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-02-03 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2020-08-05 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-05-20 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-21 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-06-20 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-12-10 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-26 | 업그레이드 | UBS | Neutral → Buy |
| 2018-08-28 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2018-07-05 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2018-01-04 | 업그레이드 | UBS | Sell → Neutral |
| 2017-12-11 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-01 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2016-09-06 | 업그레이드 | Citigroup | Neutral → Buy |
| 2016-07-08 | 업그레이드 | Jefferies | Underperform → Hold |
| 2016-01-04 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2015-11-04 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2015-09-03 | 업그레이드 | Goldman | Neutral → Buy |
| 2015-08-13 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2015-07-31 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2013-08-02 | 재확인 | Feltl & Co. | Hold |
| 2013-01-14 | 업그레이드 | HSBC Securities | Neutral → Overweight |
모두보기
프레제니우스메디칼케어 주식(FMS)의 최신 뉴스
Fresenius Medical Care Appoints Joseph Turk to Management Board - The Globe and Mail
Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement - Fresenius Medical Care
Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment - freseniusmedicalcare.com
Fresenius Medical Care Celebrates Nephrology Nurses Week with The CARE Award - freseniusmedicalcare.com
UBS downgrades Fresenius Medical Care to “sell,” warns on U.S. dialysis outlook - Investing.com
Fresenius Medical Care launches €600 million share buyback tranche - Investing.com
Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework - freseniusmedicalcare.com
Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025 - freseniusmedicalcare.com
Fresenius Medical Care ADR earnings beat by $0.41, revenue fell short of estimates - Investing.com Australia
Fresenius Medical Care Q2 results show revenue growth despite challenges - Investing.com
Fresenius Medical Care’s Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care - freseniusmedicalcare.com
Is The Options Market Predicting A Spike In Fresenius Medical Stock? - Barchart.com
"I’m in My Living Life Era”: Katelyn’s Double Transplant Journey - Fresenius Medical Care
Kidney transplantation and value-based care - Fresenius Medical Care
Why I love home dialysis as a healthcare professional working in nephrology - Fresenius Medical Care
Coming Back Home: Dr. Len Usvyat Appointed as the Next Head of the Renal Research Institute - Fresenius Medical Care
Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico - freseniusmedicalcare.com
Q2 2025 Media Call - Fresenius Medical Care
Fresenius Medical Care stock holds steady as Truist reiterates $30 target - Investing.com India
Fresenius Medical Care price target raised to €56 on medium-term outlook - Investing.com India
Fresenius Medical Care price target raised to €56 on medium-term outlook By Investing.com - Investing.com South Africa
Bernstein raises Fresenius Medical Care price target on restructuring progress - Investing.com India
Fresenius Medical Care's Narrow Moat Reinforced by Margin Expansion Plans - Morningstar
Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation - freseniusmedicalcare.com
5 Stocks To Ride The German Market RallyCureVac (NASDAQ:CVAC), BioNTech (NASDAQ:BNTX) - Benzinga
Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S. - Fresenius Medical Care
New research and innovation for kidney care at European Renal Association Congress 2025 - Fresenius Medical Care
61st ERA Congress - Fresenius Medical Care
Fresenius Medical Care sets record with dividend hike By Investing.com - Investing.com India
Fresenius Medical Care sets record with dividend hike - Investing.com
Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History - Fresenius Medical Care
ApolloDialDb™: A Dialysis Database of the Future - Fresenius Medical Care
Fresenius Medical Care ADR earnings beat by $0.07, revenue topped estimates - Investing.com
International Nurses Day 2025 - Fresenius Medical Care
Fresenius Medical Care starts 2025 with strong organic revenue and income growth - Fresenius Medical Care
Fresenius Medical Care Celebrates 40 of Dialysis Center in Sokolov, Czech Republic - Fresenius Medical Care
Fresenius Medical Care AG completes EUR 1.1 billion bond issue By Investing.com - Investing.com India
Fresenius Medical Care AG completes EUR 1.1 billion bond issue - Investing.com
Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence - Benzinga
Why Fresenius Medical Care Stock Might Be A Great Pick - Barchart.com
From Kidney Failure to Fresenius Medical Care Employee: A Transplant Story - Fresenius Medical Care
Dialysis Nurse Becomes Kidney Patient After COVID-19 - Fresenius Medical Care
What Sets Our Nurses Apart - Fresenius Medical Care
A Transplant Story: Patient Care Technician Gives Dialysis Patient the Gift of Life - Fresenius Medical Care
The Zacks Analyst Blog Highlights Reddit, Ubiquiti And Fresenius Medical Care AG - Barchart.com
Fresenius Medical Care plans bond sale stabilization - Investing.com
Dry Bicarbonate Concentrate Bags for Hemodialysis in the State of São Paulo in Brazil - freseniusmedicalcare.com
Fresenius Economic Profit Margins Should Rise Along With Improvement in Both Operating Segments - Morningstar
프레제니우스메디칼케어 (FMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.79%
자본화:
|
볼륨(24시간):